publication venue for
- Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.. 10:342-352. 2024
- Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials.. 9:299-300. 2023
- An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries.. 8:539-548. 2022